Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age PressReach · Aug 23, 2022
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine PressReach · Aug 23, 2022
Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022 PressReach · Aug 23, 2022
Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki PressReach · Aug 23, 2022
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference PressReach · Aug 23, 2022
New to The Street TV Announces Episodes #378, Five Corporate Interviews, Airing on The Fox Business Network, Tonight, Monday, August 22, 2022, at 10:30 PM PT PressReach · Aug 23, 2022
Moderna to Supply 12 Million Doses of Omicron-Containing Bivalent COVID-19 Booster Vaccines to the Government of Canada PressReach · Aug 22, 2022
Tonix Pharmaceuticals Initiates Enrollment in Phase 2 PREVAIL Study of TNX-102 SL for the Treatment of Long COVID PressReach · Aug 22, 2022
New to The Street TV Announces its Five Business Guest Interviews, Episode #376 Airs on Bloomberg TV, Saturday, August 20, 2022, at 6:30 PM ET as Sponsored Programming PressReach · Aug 20, 2022
Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics PressReach · Aug 19, 2022